
Welcome
Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Center for Research in Nanomaterials and Biomedicine (CINBIO). Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.
Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.
We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.
Follow us on Twitter to stay updated on news
Latest news
Picture selected for 2016 year calendar of the Spanish Society of Biochemistry and Molecular Biology (SEBBM)
Picture selected for 2016 year calendar of the Spanish Society of Biochemistry and Molecular Biology (SEBBM). Congrats to Paula Carpintero!
New Emergent Research Group at INIBIC. Group Head: Dr. Mayán
The goal of the CellCOM Research Group is to establish a multidisciplinary collaborative work to provide an integral approach for studying the function of the connexins and pannexins in normal…
We thank to PRECIPITA (FECYT) for including our research project in their platform
PRECIPITA is a top crowdfunding site for scientific research. The platform is part of the Spanish Foundation for Science and Technology (FECYT), Ministry of Economy and Competitiveness. Together with PRECIPITA,…